Genes in cluster 3 were significantly associated with immune response pathways including antigen presentation, Th1 and Th2 activation, B cell development, neuroinflammation signaling, PD-1 and PD-L1 cancer immunotherapy, and IL-4 signaling pathways (Fig. 4B, Supplementary Table S3). The gene discussed is IL4; the disease is cancer.